Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000795
Status:
COMPLETED
Last Update Posted:
2008-09-09
First Post:
1999-11-02
Brief Title:
A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID